Your browser doesn't support javascript.
loading
Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.
Saw, Phei Er; Cui, Guo-Hui; Xu, Xiaoding.
Afiliación
  • Saw PE; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Yuexiu District, Guangzhou, Guangdong, China.
  • Cui GH; South China National Bio-Safety Laboratory, Zhongshan School of Medicine, Sun Yat-sen University, No. 74, Zhongshan 2nd Road, Yuexiu District, Guangzhou, Guangdong, China.
  • Xu X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Yuexiu District, Guangzhou, Guangdong, China.
ChemMedChem ; 17(9): e202100777, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35261159
ABSTRACT
CRISPR/Cas system has become one of the most powerful techologies in biomedical research, and has showed great potentials in the gene related diseases. However, efficient delivery systems of CRISPR/Cas to target cells remains challenging. In recent years, nanoparticles have showned great potentials for the delivery of CRISPR/Cas systems. This paper mainly approaches the development and new strategies of CRISPR/Cas delivery systems, as well as their application in the clinical diseases. By summarizing the CRISPR/Cas systems delivery, new strategies are expected for the gene therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Edición Génica Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Edición Génica Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: China